STOCK TITAN

Tourmaline Bio, Inc. (TRML) Free Cash Flow by Year

TRML

Tourmaline Bio, Inc. recorded an outflow of $77.3M in free cash flow in fiscal year 2024. This represents a decrease of 174.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to an outflow of $86.3M in free cash flow. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Tourmaline Bio, Inc. has filed alongside them.

FY2024 annual
Free Cash Flow -$77.3M
YoY -174.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TRML Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Free Cash Flow-$86.3M-$77.3M-174.6%-$28.1M-331.2%-$6.5M+84.6%-$42.4M-107.0%-$20.5M

TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

TRML Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Free Cash Flow-$20.3M-12.6%-$21.7M-45.3%-$20.9M-123.4%-$23.4M-333.1%-$18.0M-88.5%-$14.9M-291.2%-$9.4M-124.7%-$5.4M+60.7%-$9.6M+48.0%-$3.8M+78.3%$37.8M+443.3%-$13.8M-26.8%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Tourmaline Bio, Inc. financials

Frequently Asked Questions

What was Tourmaline Bio, Inc.'s free cash flow in fiscal year 2024?

Tourmaline Bio, Inc. recorded an outflow of $77.3M in free cash flow in fiscal year 2024.

How fast is Tourmaline Bio, Inc.'s free cash flow growing?

Tourmaline Bio, Inc. (TRML) free cash flow fell by 174.6% year over year, from -$28.1M to -$77.3M in fiscal year 2024.

What is Tourmaline Bio, Inc.'s free cash flow over the last twelve months?

Tourmaline Bio, Inc. (TRML) reported an outflow of $86.3M in free cash flow over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

Across the 5 fiscal years this page covers, Tourmaline Bio, Inc. (TRML) free cash flow went from -$20.5M in fiscal year 2020 to -$77.3M in fiscal year 2024.

Tourmaline Bio, Inc. (TRML) reported -$20.3M in free cash flow in Q2 2025. This represents a decrease of 12.6% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Tourmaline Bio, Inc. (TRML) reported on that line in every period on record.